# HealthCare Global Enterprises Ltd (HCG) > Exchange: NSE | Sector: Pharma | ISIN: ## Price Current Price: ₹654.3 Day Change: +4.35% 52W High: ₹804.65 52W Low: ₹513.3 Market Cap: ₹9,440 Cr ## Valuation P/E: 471.83 P/B: 9.63 EPS: ₹1.34 Book Value: ₹65.64 Dividend Yield: 0% ## Returns 1Y Return: -15.55% ## Profitability ROE: 0% ROCE: 14.02% Debt/Equity: 1.78 Revenue Growth: 13.3% Profit Growth: 0% EBITDA Margin: 14.59% Operating Margin: 7.73% ## About HealthCare Global Enterprises Ltd is a Medical Care Facilities company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place. Sector: Pharma Industry: Medical Care Facilities Sub Industry: Unknown ## Business Model Overview: HealthCare Global Enterprises Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Medical Care Facilities. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma. Source: Derived from stock data Revenue Streams: - Domestic formulations - Exports and regulated markets - Specialty or institutional sales Operating Model: - Develops, manufactures, distributes, or services healthcare products across regulated channels. - Approvals, product mix, compliance quality, and R&D productivity shape growth. Recent Context: - Announcement: Announcement under Regulation 30 (LODR)-Monitoring Agency Report - Announcement: Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 - BSE Filing: Announcement under Regulation 30 (LODR)-Monitoring Agency Report ## Access Current tier: anonymous More history: Register free to see 9 more years. ## Data Freshness Quote Updated: 2026-05-24T20:00:11.526Z Price History Updated: 2026-05-18T22:58:28.164Z Latest Price History Date: 2026-05-18 Technicals Updated: 2026-05-18T22:58:28.164Z Quant Updated: 2026-05-18T22:58:28.164Z Sentiment Updated: 2026-05-18T22:58:28.164Z Financials Status: current Financials Updated: 2026-05-18T11:30:43.440Z Financials Last Attempt: 2026-05-18T11:30:43.440Z Financials Provider Tried: yahoo Latest P&L Period: FY25 Latest Balance Sheet Period: FY25 Latest Cash Flow Period: FY25 ## P&L (Mar 2015) Revenue: ₹451 Cr Operating Profit: ₹38 Cr (OPM 9%) Net Profit: ₹-32 Cr Tax: ₹-27 Cr ## Annual P&L History Mar 2015: Rev ₹451Cr | PAT ₹-32Cr | OPM 9% Mar 2016: Rev ₹519Cr | PAT ₹5Cr | OPM 15% Mar 2017: Rev ₹584Cr | PAT ₹2Cr | OPM 15% ## Balance Sheet (Mar 2015) Total Assets: ₹688 Cr Total Liabilities: ₹688 Cr Borrowings: ₹292 Cr Cash: ₹undefined Cr ## Shareholding undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% undefined: undefined% ## Board - Manisha Kumar, Cluster Head & COO - Sunu Manuel Abey, Compliance Officer & Company Secretary - Manish Mattoo, CEO, Interim CFO & Executive Director - V. Venkataramanan, Senior Vice President of Finance & Accounts - Pankaj Gautam, Chief Technology & Security Officer and Chief Information Officer --- Source: rupiya.io/stocks/hcg Disclaimer: For research and education only. Not investment advice.